Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure
References (16)
- et al.
Long-term efficacy and safety of coenzyme Q10 therapy for idopathic dilated cardiomyopathy
Am. J. Cardiol.
(1990) - et al.
Isolation of a quinone from beef heart mithocondria
Biochim. Biophys. Acta
(1957) - et al.
Effect of Coenzyme Q10 on essential arterial hypertension
Curr. Ther. Res. Clin. Exp.
(1990) - et al.
Mechanism of action of Coenzyme Q10 in essential hypertension
Curr. Ther. Res. Clin. Exp.
(1992) - et al.
Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10
Neuroendocrine activation in congestive heart failure
Am. J. Cardiol.
(1991)- et al.
Improved long-term survival in coenzyme Q10 treated congestive heart failure patients compared to conventionally treated patients
- et al.
Myocardial tissue levels of coenzyme Q10 in patients with cardiac failure
There are more references available in the full text version of this article.
Cited by (117)
Mitochondrial dysfunction and mitochondrial therapies in heart failure
2022, Pharmacological ResearchCoenzyme Q10 in the treatment of heart failure: A systematic review of systematic reviews
2018, Indian Heart JournalHeart Failure
2018, Integrative Medicine: Fourth EditionCoenzyme Q10 – A new player in the treatment of heart failure?
2016, Pharmacological Reports
Copyright © 1994 Published by Elsevier Ltd.